63 3 Epidemiology and control of DM-TB Comorbidity 34. Tabarsi P, Baghaei P, Marjani M, Vollmer WM, Masjedi M-R, Harries AD. Changes in glycosylated haemoglobin and treatment outcomes in patients with tuberculosis in Iran: a cohort study. Journal of Diabetes & Metabolic Disorders. 2014;13(1):1-6. 35. Moreira J, Castro R, Lamas C, Ribeiro S, Grinsztejn B, Veloso VG. Hyperglycemia during tuberculosis treatment increases morbidity and mortality in a contemporary cohort of HIV-infected patients in Rio de Janeiro, Brazil. International Journal of Infectious Diseases. 2018;69:11-9. 36. Diarra B, Tolofoudie M, Sarro Y, Togo A, Bane S, Nientao I, et al. Diabetes Mellitus among new tuberculosis patients in Bamako, Mali. Journal of clinical tuberculosis and other mycobacterial diseases. 2019;17:100128. 37. Hennink M, Hutter I, Bailey A. Qualitative research methods: Sage; 2020. 38. Organization WH. Meeting report of the WHO expert consultation on drug-resistant tuberculosis treatment outcome definitions, 17-19 November 2020. 2021. 39. Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, et al. The REDCap consortium: Building an international community of software platform partners. Journal of biomedical informatics. 2019;95:103208. 40. QSR International Pty Ltd. (2020) NVivo (released in March 2020) 2020 [cited 2021 30 October]. Available from: https://www.qsrinternational.com/nvivo-qualitative-data-analysis-software/ home.
RkJQdWJsaXNoZXIy MTk4NDMw